Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.40 |
| ▸ | STS | P08842 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | MPO | P05164 | 1/20 | 0.35 |
| ▸ | TPO | P07202 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | BACE1 | P56817 | 1/20 | 0.33 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.33 |
| ▸ | KAT6A | Q92794 | 2/20 | 0.33 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.33 |
| ▸ | NPC1 | O15118 | 2/20 | 0.33 |
| ▸ | RAB9A | P51151 | 2/20 | 0.33 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.31 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
| ▸ | HTR2A | P28223 | 1/20 | 0.30 |
| ▸ | HTR2C | P28335 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2360049 | 0.83 | KEAP1 (0.53) | L3MBTL1STSKEAP1NPC1RAB9A | |
| SCHEMBL20241942 | 0.82 | ELOVL1 (0.44) | L3MBTL1KMT2AMEN1ALDH1A1MPO | |
| SCHEMBL2159964 | 0.82 | KMT2A (0.49) | L3MBTL1KMT2AMEN1ALDH1A1MPO | |
| SCHEMBL2130372 | 0.77 | FAAH (0.39) | L3MBTL1KMT2AMEN1ALDH1A1MPO | |
| SCHEMBL30780893 | 0.76 | ALDH1A1 (0.40) | ALDH1A1CYP3A4BACE1 | |
| Trifluoroacetic Acid SCHEMBL31456974 | 0.75 | KLKB1 (0.37) | L3MBTL1KMT2AKAT6AKDM4E | |
| SCHEMBL27097065 | 0.74 | L3MBTL1 (0.36) | L3MBTL1KMT2AMEN1ALDH1A1BACE1 | |
| SCHEMBL20241993 | 0.74 | ELOVL1 (0.42) | L3MBTL1KMT2AMEN1ALDH1A1MPO | |
| SCHEMBL20250029 | 0.73 | CA12 (0.42) | KMT2AMEN1KCNH2 | |
| SCHEMBL15090773 | 0.73 | SCN9A (0.46) | L3MBTL1STSKMT2AALDH1A1KAT6A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2408767-B1 | AMIDE DERIVATIVES AS NEUROPEPTIDE Y5 RECEPTOR LIGANDS | LUNDBECK & CO AS H (DK) | 2013-07-10 | — | — | EP | claimed |
| WO-2010108052-A2 | AMIDE DERIVATIVES AS NEUROPEPTIDE Y5 RECEPTOR LIGANDS | H. LUNDBECK A/S (DK) | 2010-09-23 | — | — | WO | claimed |
| WO-2025121409-A1 | NITROGEN-CONTAINING AROMATIC HETEROCYCLIC AND AROMATIC CARBOCYCLIC DERIVATIVE HAVING SEROTONIN RECEPTOR BINDING ACTIVITY | シオノギ－アプニメッド スリープ サイエンス、エルエルシー | 2025-06-12 | — | — | WO | disclosed |
| US-20180251431-A1 | 1,3-SUBSTITUTED PYRAZOLE COMPOUNDS USEFUL FOR REDUCTION OF VERY LONG CHAIN FATTY ACID LEVELS | VERTEX PHARMACEUTICALS INCORPORATED | 2018-09-06 | — | — | US | disclosed |
| WO-2018107056-A1 | 1,3-SUBSTITUED PYRAZOLE COMPOUNDS USEFUL FOR REDUCTION OF VERY LONG CHAIN FATTY ACIC LEVELS | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2018-06-14 | — | — | WO | disclosed |
| WO-2018107056-A1 | 1,3-SUBSTITUED PYRAZOLE COMPOUNDS USEFUL FOR REDUCTION OF VERY LONG CHAIN FATTY ACIC LEVELS | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2018-06-14 | — | — | WO | disclosed |
| CN-103339129-B | Azaindazole or diazaindazole derivatives as medicaments | PIERRE FABRE MEDICAMENT (FR) | 2015-07-29 | — | — | CN | disclosed |
| CN-104684554-A | Derivatives of azaindazole or diazaindazole type for treating pain | PF MEDICAMENT | 2015-06-03 | — | — | CN | disclosed |
| CN-103339129-A | Azaindazole or diazaindazole derivatives as medicaments | PF MEDICAMENT | 2013-10-02 | — | — | CN | disclosed |
| EP-2408767-B1 | AMIDE DERIVATIVES AS NEUROPEPTIDE Y5 RECEPTOR LIGANDS | LUNDBECK & CO AS H (DK) | 2013-07-10 | — | — | EP | disclosed |
| EP-2408767-B1 | AMIDE DERIVATIVES AS NEUROPEPTIDE Y5 RECEPTOR LIGANDS | LUNDBECK & CO AS H (DK) | 2013-07-10 | — | — | EP | disclosed |
| EP-2408767-A2 | AMIDE DERIVATIVES AS NEUROPEPTIDE Y5 RECEPTOR LIGANDS | H. Lundbeck A/S (DK) | 2012-01-25 | — | — | EP | disclosed |
| US-20110230497-A1 | BIOLOGICALLY ACTIVE AMIDES | H. LUNDBECK A/S (DK) | 2011-09-22 | — | — | US | disclosed |
| EP-2352730-A2 | BIOLOGICALLY ACTIVE AMIDES | H. Lundbeck A/S (DK) | 2011-08-10 | — | — | EP | disclosed |
| WO-2010108052-A2 | AMIDE DERIVATIVES AS NEUROPEPTIDE Y5 RECEPTOR LIGANDS | H. LUNDBECK A/S (DK) | 2010-09-23 | — | — | WO | disclosed |
| WO-2010108052-A2 | AMIDE DERIVATIVES AS NEUROPEPTIDE Y5 RECEPTOR LIGANDS | H. LUNDBECK A/S (DK) | 2010-09-23 | — | — | WO | disclosed |
| WO-2010053861-A2 | BIOLOGICALLY ACTIVE AMIDES | H. LUNDBECK A/S (DK) | 2010-05-14 | — | — | WO | disclosed |
| US-20060014815-A1 | Process for making pyrazole compounds | MSD K.K. (JP) | 2006-01-19 | — | — | US | disclosed |
| EP-1554251-A1 | PROCESS FOR MAKING PYRAZOLE COMPOUNDS | BANYU PHARMACEUTICAL CO., LTD. (JP) | 2005-07-20 | — | — | EP | disclosed |
| WO-2004037794-A1 | PROCESS FOR MAKING PYRAZOLE COMPOUNDS | BANYU PHARMACEUTICAL CO., LTD (JP) | 2004-05-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110230497-A1 | BIOLOGICALLY ACTIVE AMIDES | NPY5R, NPY1R, NPY2R | L3MBTL1 4398/4885STS 1879/4885KMT2A 3489/4885 |
| US-20060014815-A1 | Process for making pyrazole compounds | CYP3A5, CYP1B1, CYP3A4 | L3MBTL1 4721/4885STS 399/4885KMT2A 3748/4885 |
| US-20180251431-A1 | 1,3-SUBSTITUTED PYRAZOLE COMPOUNDS USEFUL FOR REDUCTION OF VERY LONG CHAIN FATTY ACID LEVELS | HSD17B4, CPT1A, ADH1A | L3MBTL1 1581/4885STS 765/4885KMT2A 2360/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.